Catalyst Biosciences Inc (CBIO)

Catalyst Biosciences Stock Analysis & Ratings

CBIO Stock Chart & Stats

Day’s Range$1.03 - $1.36
52-Week Range$0.35 - $5.20
Previous Close$1.27
Average Volume (3M)3.11M
Market Cap$36.63M
P/E Ratio-0.5
Next EarningsAug 04, 2022
Dividend YieldN/A
Smart Score5
EPS (TTM)-2.55



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Catalyst Biosciences’s price range in the past 12 months?
Catalyst Biosciences lowest stock price was $0.35 and its highest was $5.20 in the past 12 months.
    What is Catalyst Biosciences’s market cap?
    Catalyst Biosciences’s market cap is $36.63M.
      What is Catalyst Biosciences’s price target?
      The average price target for Catalyst Biosciences is $3.00. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $3.00 ,the lowest forecast is $3.00. The average price target represents 152.10% Increase from the current price of $1.19.
        What do analysts say about Catalyst Biosciences?
        Catalyst Biosciences’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
          When is Catalyst Biosciences’s upcoming earnings report date?
          Catalyst Biosciences’s upcoming earnings report date is Aug 04, 2022 which is in 72 days.
            How were Catalyst Biosciences’s earnings last quarter?
            Currently, no data Available
            Is Catalyst Biosciences overvalued?
            According to Wall Street analysts Catalyst Biosciences’s price is currently Undervalued.
              Does Catalyst Biosciences pay dividends?
              Catalyst Biosciences pays a Notavailable dividend of $173.16 which represents an annual dividend yield of N/A. Catalyst Biosciences’s last Notavailable dividend payment was on Aug 19, 2015. Catalyst Biosciences’s upcoming ex-dividend date is Aug 20, 2015
                What is Catalyst Biosciences’s EPS estimate?
                Catalyst Biosciences’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Catalyst Biosciences have?
                Catalyst Biosciences has 30,780,000 shares outstanding.
                  What happened to Catalyst Biosciences’s price movement after its last earnings report?
                  Currently, no data Available
                  Which hedge fund is a major shareholder of Catalyst Biosciences?
                  Among the largest hedge funds holding Catalyst Biosciences’s share is Ellington Management Group LLC. It holds Catalyst Biosciences’s shares valued at N/A.


                    Catalyst Biosciences Stock Analysis

                    The Catalyst Biosciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Catalyst Biosciences Inc

                    Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.

                    Similar Stocks
                    Price & Change
                    IVERIC bio
                    Abeona Therapeutics
                    Nektar Therapeutics

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis